1. Medtech Insight
  2. >>Business
  3. >>Deals

Recipharm Boosts Inhalation And Injectables Manufacturing By Acquiring UK’s Consort Medical

 
• By Marion Webb

Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company. 

Business handshake / contract agreement flat vector icon for apps and websites - Vector

Swedish pharmaceutical group Recipharm AB announced on 18 November that it had struck a deal to buy UK-based respiratory device and contract manufacturer Consort Medical PLC for £505m ($652m), bolstering Recipharm's annual revenue to $1.1bn.

Recipharm, which develops and manufactures products for pharmaceutical and smaller R&D companies on a contract basis, said the deal would...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Somnee AI-Powered Sleep Wearable Raises $10M Seed Round

 
• By Natasha Barrow

The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.

Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation

 
• By Shubham Singh

Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.

Three Steps To Investor Heaven For Medtech Founders: Articulate, Explain, Clarify

 
• By Ashley Yeo

Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.